| 1 |
33941195 | Unclassified mesenchymal sarcoma with NTRK1-KHDRBS1 gene fusion: a case report of long-term tumor-free survival with crizotinib treatment. | 2021 Apr 30 |
1 |
| 2 |
30691963 | Durable Clinical Response to Crizotinib in IRF2BP2-NTRK1 Non-small-cell Lung Cancer. | 2019 May |
1 |
| 3 |
30709876 | Refractory and metastatic infantile fibrosarcoma harboring LMNA-NTRK1 fusion shows complete and durable response to crizotinib. | 2019 Feb |
2 |
| 4 |
31213843 | Complete response to crizotinib in a metastatic adenocarcinoma of unknown primary harboring MET amplification and NTRK1 co-occurring mutation. | 2019 |
1 |
| 5 |
30134855 | A primary undifferentiated pleomorphic sarcoma of the lumbosacral region harboring a LMNA-NTRK1 gene fusion with durable clinical response to crizotinib: a case report. | 2018 Aug 22 |
3 |
| 6 |
29125233 | In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs. | 2017 Dec |
1 |
| 7 |
26563356 | Evaluation of a Congenital Infantile Fibrosarcoma by Comprehensive Genomic Profiling Reveals an LMNA-NTRK1 Gene Fusion Responsive to Crizotinib. | 2016 Jan |
1 |